Literature DB >> 11158971

Importance of ventilation in modulating interaction between sympathetic drive and cardiovascular variability.

P Van De Borne1, N Montano, K Narkiewicz, J P Degaute, A Malliani, M Pagani, V K Somers.   

Abstract

Chemoreflex stimulation elicits both hyperventilation and sympathetic activation, each of which may have different influences on oscillatory characteristics of cardiovascular variability. We examined the influence of hyperventilation on the interactions between changes in R-R interval (RR) and muscle sympathetic nerve activity (MSNA) and changes in neurocirculatory variability, in 14 healthy subjects. We performed spectral analysis of RR and MSNA variability during each of the following interventions: 1) controlled breathing, 2) maximal end-expiratory apnea, 3) isocapnic voluntary hyperventilation, and 4) hypercapnia-induced hyperventilation. MSNA increased from 100% during controlled breathing to 170 +/- 25% during apnea (P = 0.02). RR was unchanged, but normalized low-frequency (LF) variability of both RR and MSNA increased markedly (P < 0.001). During isocapnic hyperventilation, minute ventilation increased to 20.2 +/- 1.4 l/min (P < 0.0001). During hypercapnic hyperventilation, minute ventilation also increased (to 19.7 +/- 1.7 l/min) as did end-tidal CO(2) (both P < 0.0001). MSNA remained unchanged during isocapnic hyperventilation (104 +/- 7%) but increased to 241 +/- 49% during hypercapnic hyperventilation (P < 0.01). RR decreased during both isocapnic and hypercapnic hyperventilation (P < 0.05). However, normalized LF variability of RR and of MSNA decreased (P < 0.05) during both isocapnic and hypercapnic hyperventilation, despite the tachycardia and heightened sympathetic nerve traffic. In conclusion, marked respiratory oscillations in autonomic drive induced by hyperventilation may induce dissociation between RR, MSNA, and neurocirculatory variability, perhaps by suppressing central genesis and/or inhibiting transmission of LF cardiovascular rhythms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158971     DOI: 10.1152/ajpheart.2001.280.2.H722

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Sympathetic nerve activity and simulated diving in healthy humans.

Authors:  Abu Shamsuzzaman; Michael J Ackerman; Fatima Sert Kuniyoshi; Valentina Accurso; Diane Davison; Raouf S Amin; Virend K Somers
Journal:  Auton Neurosci       Date:  2013-12-12       Impact factor: 3.145

2.  Interstrain variation in cardiac and respiratory adaptation to repeated ozone and particulate matter exposures.

Authors:  Ali K Hamade; Clarke G Tankersley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

3.  The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance.

Authors:  George E Billman
Journal:  Front Physiol       Date:  2013-02-20       Impact factor: 4.566

4.  Impact of Altered Breathing Patterns on Interaction of EEG and Heart Rate Variability.

Authors:  Meenakshi Sinha; Ramanjan Sinha; Jayshri Ghate; Gaurav Sarnik
Journal:  Ann Neurosci       Date:  2020-11-09

5.  Vestibular influence on the cardiorespiratory responses to whole-body oscillation after standing.

Authors:  A Thurrell; K Jáuregui-Renaud; M A Gresty; A M Bronstein
Journal:  Exp Brain Res       Date:  2003-04-11       Impact factor: 1.972

6.  A blood pressure monitoring method for stroke management.

Authors:  Heather Ting Ma
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

7.  Neuro-autonomic changes induced by remote ischemic preconditioning (RIPC) in healthy young adults: Implications for stress.

Authors:  Igor Khaliulin; Arnold N Fleishman; Nadezhda I Shumeiko; TatyanaV Korablina; Stanislav A Petrovskiy; Raimondo Ascione; M-Saadeh Suleiman
Journal:  Neurobiol Stress       Date:  2019-07-27

8.  Vagal Threshold Determination during Incremental Stepwise Exercise in Normoxia and Normobaric Hypoxia.

Authors:  Filip Neuls; Jakub Krejci; Ales Jakubec; Michal Botek; Michal Valenta
Journal:  Int J Environ Res Public Health       Date:  2020-10-19       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.